Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Evaluation Review
|
July 11, 2007
Four criteria to evaluate providers' service-delivery response to new contraceptive introduction
Federico R León, Marcos Arévalo, Rebecka Lundgren, et al.
Women'S Health Reports (New Rochelle, N.Y.)
|
March 31, 2021
A Mixed-Methods Assessment of Health Care Providers' Knowledge, Attitudes, and Practices Around Fertility Awareness-Based Methods in Title X Clinics in the United States
Shelby Webb, An-Lin Cheng, Rebecca Simmons, et al.
The Journal of Family Planning and Reproductive Health Care
|
October 13, 2006
Quality of delivery of the Standard Days Method as compared with contraceptive pills in Rwanda
Federico R León, Caroline Blair, Ana Huapaya, et al.
Lancet (London, England)
|
May 22, 2002
Fertilisation involving ageing gametes, major birth defects, and Down's syndrome
Joe Leigh Simpson, Ron Gray, Alfredo Perez, et al.
Molecular Oncology
|
October 28, 2024
Malformin C preferentially kills glioblastoma stem-like cells via concerted induction of proteotoxic stress and autophagic flux blockade
Emma Phillips, Sizèd van Enk, Sara Kildgaard, et al.
Journal for Immunotherapy of Cancer
|
March 20, 2021
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche
Louise M E Müller, Gemma Migneco, Gina B Scott, et al.
Journal for Immunotherapy of Cancer
|
July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling
Edward Armstrong, Matthew K L Chiu, Shane Foo, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2022
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma
Galabina Bozhanova, Jehanne Hassan, Lizzie Appleton, et al.
Nature Communications
|
July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models
Joan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Journal of Crohn'S & Colitis
|
June 10, 2026
The CONTEXT trial: Real world clinical use of GIQuant-a motility MRI based activity biomarker for small bowel Crohn's disease
Alex Menys, Iyad Naim, Joy Barber, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Evaluation Review
|
July 11, 2007
Four criteria to evaluate providers' service-delivery response to new contraceptive introduction
Federico R León, Marcos Arévalo, Rebecka Lundgren, et al.
Women'S Health Reports (New Rochelle, N.Y.)
|
March 31, 2021
A Mixed-Methods Assessment of Health Care Providers' Knowledge, Attitudes, and Practices Around Fertility Awareness-Based Methods in Title X Clinics in the United States
Shelby Webb, An-Lin Cheng, Rebecca Simmons, et al.
The Journal of Family Planning and Reproductive Health Care
|
October 13, 2006
Quality of delivery of the Standard Days Method as compared with contraceptive pills in Rwanda
Federico R León, Caroline Blair, Ana Huapaya, et al.
Lancet (London, England)
|
May 22, 2002
Fertilisation involving ageing gametes, major birth defects, and Down's syndrome
Joe Leigh Simpson, Ron Gray, Alfredo Perez, et al.
Molecular Oncology
|
October 28, 2024
Malformin C preferentially kills glioblastoma stem-like cells via concerted induction of proteotoxic stress and autophagic flux blockade
Emma Phillips, Sizèd van Enk, Sara Kildgaard, et al.
Journal for Immunotherapy of Cancer
|
March 20, 2021
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche
Louise M E Müller, Gemma Migneco, Gina B Scott, et al.
Journal for Immunotherapy of Cancer
|
July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling
Edward Armstrong, Matthew K L Chiu, Shane Foo, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2022
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma
Galabina Bozhanova, Jehanne Hassan, Lizzie Appleton, et al.
Nature Communications
|
July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models
Joan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Journal of Crohn'S & Colitis
|
June 10, 2026
The CONTEXT trial: Real world clinical use of GIQuant-a motility MRI based activity biomarker for small bowel Crohn's disease
Alex Menys, Iyad Naim, Joy Barber, et al.
Page
of 4